Eli Lilly and Co. today launched its first insulin injector pen with a digital memory in the hope of regaining market share lost in recent years to generic and inhalable insulin. HumaPen Memoir resembles a writing pen and is designed for patients who take several daily shots of insulin at mealtimes.
The
Please enable JavaScript to view this content.